Prenatal testing for Imprinting Disorders: A clinical perspective
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Andreas Dufke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Genomic Imprinting, Prenatal Diagnosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Imprinting Disorders (ImpDis) are a group of congenital conditions caused by aberrant imprinting resulting in disturbed expression of parentally imprinted genes. ImpDis are rarely associated with major malformations, but pre‐ and/or postnatal growth and nutrition are often affected. In some ImpDis, behavioral, developmental, metabolic and neurological symptoms might present in the perinatal context or later in life, and in single ImpDis, there is a higher risk of tumors in childhood. Prognosis depends in part on the molecular cause of each ImpDis, but due to high clinical variability and (epi)genetic mosaicism, predicting the clinical outcome of a pregnancy solely based on the underlying molecular disturbance is difficult. Therefore, interdisciplinary care and treatment approaches play an important role in the management and decision making of affected pregnancies, especially taking into account fetal imaging in addition to genetic findings. Prenatal findings influence perinatal management, and thereby improve the prognosis of ImpDis associated with severe but sometimes transient clinical complications in the neonatal period. Therefore, prenatal diagnosis can be crucial for appropriate management not only to the pregnancy itself but might also have a life‐long effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
- Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.
- Institute for Human Genetics and Genome Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
- Department for Women's Health, University Hospital of Tübingen, Tübingen, Germany.
ORCID-Profile: Andreas Dufke, Thomas Eggermann, Karl Oliver Kagan
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Dufke, A., Eggermann, T., Kagan, K. O., Hoopmann, M., & Elbracht, M. (2023). Prenatal testing for Imprinting Disorders: A clinical perspective. Prenatal Diagnosis. https://doi.org/10.1002/pd.6400
Vancouver
Dufke A, Eggermann T, Kagan KO, Hoopmann M, Elbracht M. Prenatal testing for Imprinting Disorders: A clinical perspective. Prenatal Diagnosis. 2023. doi:10.1002/pd.6400
BibTeX
@article{Dufke2023,
author = {Dufke, Andreas and Eggermann, Thomas and Kagan, Karl Oliver and Hoopmann, Markus and Elbracht, Miriam},
title = {Prenatal testing for Imprinting Disorders: A clinical perspective},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6400}
}
EUVIMED